STAT Plus: Biotech faces a crisis in credibility fueled by boom-era hubris
XAVIER LEOTY/AFP/GETTY IMAGES
Industry executives seem to be forgetting that it is far better to underpromise and overdeliver than the other way around.
Clinical and Molecular Allergy
Hace 16 horas
No hay comentarios:
Publicar un comentario